Company profile: Biofer
1.1 - Company Overview
Company description
- Provider of organic and inorganic medicinal chemicals and active pharmaceutical ingredients, including iron complexes for anemia, heparins and glycosaminoglycans as antithrombotics to prevent blood clots, steroids for anti-shock and antiallergic uses, folinates as antitumor adjuvants supporting cancer therapies, and enzymes as anti-inflammatories.
Products and services
- Enzymes: Biofer produces organic medicinal enzyme products applied as anti-inflammatories to reduce inflammation in medical conditions, delivering anti-inflammatory activity for therapeutic use
- Folinates: Biofer engineers organic medicinal folinate products that serve as antitumor adjuvants, supporting cancer treatment therapies with adjuvant activity
- Heparins and Glycosaminoglycans: Biofer supplies organic medicinal heparins and glycosaminoglycans used as antithrombotic agents to prevent blood clots, enabling clot prevention through antithrombotic action
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Biofer
Trinity Life Sciences
HQ: United States
Website
- Description: Provider of strategic and tactical insights for pharmaceutical and biotech, offering Trinity Infinity for integrated strategy, insights, and analytics; Customer Engagement Solutions; Trinity Real Insights predictive insights integrating market research and real-world data; Brand Insights AI; comprehensive market research; and pricing studies to optimize clinical and commercial decision-making.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Trinity Life Sciences company profile →
Biopta
HQ: United Kingdom
Website
- Description: Provider of human tissue-based contract research services for drug development, using ethically donated fresh human tissues from surgery to predict drug behavior and bridge animal studies and clinical trials. Services include fresh human tissue pharmacology, a digital human tissue assay catalog, Alvetex 3D tissue models, REPROSKIN full-thickness skin, neurite outgrowth models, and clinical lab services with AI-driven biospecimen analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biopta company profile →
Girindus
HQ: Germany
Website
- Description: Provider of solid-phase oligonucleotide manufacturing and customer-driven services for pharmaceutical clients, including process development, analytical method development, radiolabeling, cGMP-compliant scale-up, active ingredient manufacturing, and regulatory support, with expertise in both oligonucleotide and small molecule.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Girindus company profile →
Q1 Scientific
HQ: Ireland
Website
- Description: Provider of environmentally controlled stability storage services for the pharmaceutical, medical device and life sciences industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Q1 Scientific company profile →
KGK Science
HQ: Canada
Website
- Description: Provider of customized clinical trials, virtual trials (Participant Reported Outcomes and Customized Virtual Trials), preclinical studies, and regulatory consulting for the nutraceutical, cannabis, hemp, psychedelic, dietary supplement, functional food, beverage, ingredient, and cosmetic industries, supporting product development, claim substantiation, and regulatory submissions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full KGK Science company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Biofer
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Biofer
2.2 - Growth funds investing in similar companies to Biofer
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Biofer
4.2 - Public trading comparable groups for Biofer
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →